This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A randomized, double blind, two arm, parallel, pla...
Clinical trial

A randomized, double blind, two arm, parallel, placebo controlled study of rimonabant 20mg effect on high density lipoprotein kinetics in patients with abdominal obesity and additional cardiometabolic risk factors

Read time: 1 mins
Last updated:29th Dec 2006
The Primary End-point is the fractional catabolic rate of ApoA-I in HDL after 12 months of treatment.
Category Value
Study start date 2006-12-29

View full details